Plattform, Empatica

Die Plattform von Empatica erhält neue FDA-Zulassung für digitale kardiale Biomarker

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

Empatica Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Massachusetts United States of America

en | boerse | 67922372 |